A Study of Dexmedetomidine Pharmacokinetics for Preoperative Sedation
NCT ID: NCT03800641
Last Updated: 2022-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
45 participants
INTERVENTIONAL
2019-01-11
2020-01-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acceptable Hemodynamic Changes in Dexmedetomidine for Single Intravenous Bolus Injection
NCT03655847
Pharmacokinetic Study of Dexmedetomidine After Intra-nasal Dosing in Children
NCT02836431
The Study of Different Sedative Medications in Monitored Anesthesia Care During Eye Surgery With Local Anesthesia
NCT04018703
Different Premedication in Pediatric Patients
NCT04266340
Safety, Pharmacokinetics and Pharmacodynamics of Intranasal Dexmedetomidine in Healthy Subjects
NCT03293277
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
oral administration
oral administration of dexmedetomidine 4μg/kg
Dexmedetomidine
oral, intravenous and nasal administration of Dexmedetomidine
intravenous administration
intravenous administration of dexmedetomidine 0.8μg/kg
Dexmedetomidine
oral, intravenous and nasal administration of Dexmedetomidine
nasal administration
nasal administration of dexmedetomidine 1μg/kg
Dexmedetomidine
oral, intravenous and nasal administration of Dexmedetomidine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine
oral, intravenous and nasal administration of Dexmedetomidine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eye & ENT Hospital of Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jinhong Wu
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eye, Ear, Nose and Throat Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wu J, Han Y, Lu Y, Zhuang Y, Li W, Jia J. Perioperative Low Dose Dexmedetomidine and Its Effect on the Visibility of the Surgical Field for Middle Ear Microsurgery: A Randomised Controlled Trial. Front Pharmacol. 2022 Feb 8;13:760916. doi: 10.3389/fphar.2022.760916. eCollection 2022.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EyeEntFudan
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.